Cargando…

Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy

Three cardinal manifestations of neoplasia, namely inflammation, immune dysfunction, and coagulopathy are also seen in patients with severe SARS-CoV-2 infection, providing a biological rationale for testing selected anticancer drugs for their ability to control the symptoms and/or modify the course...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saini, Kamal S., Lanza, Carlo, Romano, Marco, de Azambuja, Evandro, Cortes, Javier, de las Heras, Begoña, de Castro, Javier, Lamba Saini, Monika, Loibl, Sibylle, Curigliano, Giuseppe, Twelves, Chris, Leone, Manuela, Patnaik, Mrinal M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307309/ https://www.ncbi.nlm.nih.gov/pubmed/32572174 http://dx.doi.org/10.1038/s41416-020-0948-x

Ejemplares similares

Effect of the COVID-19 pandemic on cancer treatment and research
por: Saini, Kamal S, et al.
Publicado: (2020)

Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies
por: Saini, Kamal S., et al.
Publicado: (2020)

Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months
por: de las Heras, Begoña, et al.
Publicado: (2020)

Emerging issues related to COVID-19 vaccination in patients with cancer
por: Saini, Kamal S., et al.
Publicado: (2021)

Reimagining Global Oncology Clinical Trials for the Postpandemic Era: A Call to Arms
por: Saini, Kamal S., et al.
Publicado: (2020)

Studying the coagulopathy of COVID-19
por: Spyropoulos, Alex C, et al.
Publicado: (2022)

Albendazole repurposing on VEGFR-2 for possible anticancer application: In-silico analysis
por: Gaikwad, Nikita Maruti, et al.
Publicado: (2023)

Repurposing anticancer drugs for the management of COVID-19
por: El Bairi, Khalid, et al.
Publicado: (2020)

Comment on the Article “A Lightweight and Low-Power UAV-Borne Ground Penetrating Radar Design for Landmine Detection”
por: López, Yuri Álvarez, et al.
Publicado: (2020)

Dental loss, oral health and hereditary coagulopathies
por: Coracin, Fábio Luiz
Publicado: (2013)

Estimating Mortality in Patients with Hematological Malignancy and COVID-19: A Pooled Analysis of 10 Studies
por: Saini, Kamal S., et al.
Publicado: (2020)

Drug repurposing in cardiology
por: van Driel, B. O., et al.
Publicado: (2020)

COVID-19 vaccines in patients with cancer
por: Trapani, Dario, et al.
Publicado: (2021)

From common to rare: repurposing of bempedoic acid for the treatment of glycogen storage disease type 1
por: Das, Anibh M.
Publicado: (2023)

Long COVID: systemic inflammation and obesity as therapeutic targets
por: Florencio, Lidiane L, et al.
Publicado: (2022)

COVID-19 and systemic anticancer therapy: exploiting uncertainty
por: Gelderblom, Hans, et al.
Publicado: (2021)

Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA
por: Ades, Felipe, et al.
Publicado: (2017)

Determining lines of therapy in patients with solid cancers: a proposed new systematic and comprehensive framework
por: Saini, Kamal S., et al.
Publicado: (2021)

Drug repurposing in autosomal dominant polycystic kidney disease: back to the future with pioglitazone
por: Mao, Zhiguo, et al.
Publicado: (2021)

Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients
por: de las Heras, Begoña, et al.
Publicado: (2022)

Repurposing Tranexamic Acid as an Anticancer Agent
por: Law, Mary E., et al.
Publicado: (2022)

Bevacizumab and Breast Cancer: A Meta-Analysis of First-Line Phase III Studies and a Critical Reappraisal of Available Evidence
por: Rossari, José R., et al.
Publicado: (2012)

Drug Repurposing Campaigns for Human Cytomegalovirus Identify a Natural Compound Targeting the Immediate-Early 2 (IE2) Protein: A Comment on “The Natural Flavonoid Compound Deguelin Inhibits HCMV Lytic Replication within Fibroblasts”
por: Mercorelli, Beatrice, et al.
Publicado: (2019)

Comment on “Outcomes of autologous transplantation for multiple myeloma according to different induction regimens”
por: de la Rubia, Javier
Publicado: (2014)

Addressing influenza’s underestimated burden – Iberian experts call to action
por: Gil-de-Miguel, Ángel, et al.
Publicado: (2023)

The wisdom of crowds and the repurposing of artesunate as an anticancer drug
por: Augustin, Yolanda, et al.
Publicado: (2015)

Anticancer Properties of Fenofibrate: A Repurposing Use
por: Lian, Xin, et al.
Publicado: (2018)

Fruit fly for anticancer drug discovery and repurposing
por: Nainu, Firzan, et al.
Publicado: (2023)

Single atom catalysis: a decade of stunning progress and the promise for a bright future
por: Mitchell, Sharon, et al.
Publicado: (2020)

Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease
por: Albiñana, Virginia, et al.
Publicado: (2017)

Debate over the importance and meaning of native range in invasion biology: reply to Courchamp et al.
por: Pereyra, Patricio Javier, et al.
Publicado: (2020)

The importance of sharing global forest data in a world of crises
por: Liang, Jingjing, et al.
Publicado: (2020)

Biobanking in the era of precision oncology
por: Saini, Kamal S., et al.
Publicado: (2015)

The COVID-19 pandemic and pediatric mental health: advocating for improved access and recognition
por: Dalabih, Abdallah, et al.
Publicado: (2022)

I-SPY 2: optimising cancer drug development in the 21st century
por: Bartsch, Rupert, et al.
Publicado: (2016)

Advanced Driver Assistance Systems (ADAS) Based on Machine Learning Techniques for the Detection and Transcription of Variable Message Signs on Roads
por: De-Las-Heras, Gonzalo, et al.
Publicado: (2021)

Yield, variability, reliability, and stability of two-dimensional materials based solid-state electronic devices
por: Lanza, Mario, et al.
Publicado: (2020)

A new paradigm in bench to bedside research, with a stop in the dusty pharmaceutical cabinet?
por: Balasubramaniam, Vivek, et al.
Publicado: (2021)

Value of MRI to Improve Deep Learning Model That Identifies High-Grade Prostate Cancer. Comment on Gentile et al. Optimized Identification of High-Grade Prostate Cancer by Combining Different PSA Molecular Forms and PSA Density in a Deep Learning Model. Diagnostics 2021, 11, 335
por: Jue, Joshua S., et al.
Publicado: (2021)

Targeted therapies in breast cancer: are heart and vessels also being targeted?
por: Criscitiello, Carmen, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_doh5ejj9hfatv93lgmlqk6s452